Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Erdinc Sezgin, who will be part of the prestigious SciLifeLab Fellowship programme and the Karolinska Institutet.

Formerly a member of the Eggeling lab at MRC HIU, Erdinc will lead the Cell Signalling, Immunity and Nanoimaging Lab (CSI:Nano), working on biophysical and physicochemical aspects of cell signalling using advanced technologies in imaging and synthetic biology.

The SciLifeLab Fellows program is a career program aimed at strengthening Swedish research in Molecular Biosciences and supporting a long-term societal impact. The Sezgin group is specifically hosted by the Karolinska Institutet. The host universities provide an advantageous economic starting package and together with SciLifeLab, a strong interdisciplinary research environment in close proximity to a cutting-edge research infrastructure.

SciLifeLab, Science for Life Laboratory, was founded in 2010 as a joint effort between four universities: Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University and Uppsala University. Today, they support research activities at all major Swedish universities.

We wish all the best to Erdinc in his future endeavours. More information about the Sezgin group can be found here.

Similar stories

New study maps the development of the human intestine

MRC HIU RDM

Researchers in the Simmons lab chart the embryonic origins and appearance of diverse intestinal cellular compartments, with important implications for intestinal diseases.

MRC HIU appoints new Director

MRC HIU RDM

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

Study uncovers how low blood iron diminishes immune response

MRC HIU NDM RDM

The Drakesmith group finds that low blood serum iron levels can inhibit T-cell and B-cell immune responses to vaccines and infections.

Study finds new human blood disorder

MRC MHU RDM

The Patel Group have discovered a new human disease caused by formaldehyde accumulation in cells

Interferon-b trial shows positive results

COVID-19 MRC HIU NDM

A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients. MRC HIU's Professor Ling-Pei Ho is one of the main co-authors on the paper.